High dose chemotherapy (HDCT) plus autologous stem cell transplantation (ASCT) in multiple sclerosis (Ms) patients: Follow-up results of a prospective multicenter study

被引：0
|
作者：
Shevchenko, Y. L.
Novik, A. A.
Kuznetcov, A. N.
Afanasiev, B. V.
Lisukov, I. A.
Rykavicin, O. A.
Myasnikov, A. A.
Ionova, T. I.
Melnichenko, V. J.
Fedorenko, D. A.
Kryglina, R. V.
Kishtovich, A. V.
Ivanov, R. A.
Gorodokin, G. J.
机构：
[1] Natl Pirogov Med Surg Ctr, Moscow, Russia
[2] Pavlov State Med Univ, St Petersburg, Russia
[3] Russian Acad Sci, Inst Clin Immunol, Siberian Branch, Novosibirsk, Russia
[4] Burdenko Cent Mil Hosp, Moscow, Russia
[5] Republ Hosp, Petrozavodsk, Russia
[6] Multinatl Ctr Qual Life Res, St Petersburg, Russia
[7] New Jersey Ctr Qual Life & Hlth Outcome Res, New Jersey, NJ USA
来源：
EXPERIMENTAL HEMATOLOGY | 2007年 / 35卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：24 / 24
页数：1
相关论文
共 50 条
  • [21] Efficacy of high dose chemotherapy (HDCT) and autologous stem cell transplantation (ASCT) in metastatic breast cancer with bone only disease (BOD).
    Ponnuri, J
    Vij, R
    Adkins, D
    Brown, R
    Khoury, H
    Duerst, R
    Liesveld, J
    Abboud, C
    Dipersio, J
    BLOOD, 1999, 94 (10) : 351A - 351A
  • [22] Outcomes of Daratumumab, Pomalidomide, and Dexamethasone (DPd) Followed by High-Dose Chemotherapy and Autologous Stem Cell Transplantation (HDCT/ASCT) in Patients with Relapsed/Refractory Multiple Myeloma (RRMM)
    Abdallah, Al-Ola
    Mohyuddin, Ghulam Rehman
    Mahmoudjafari, Zahra
    Shebli, Atrash
    Kawsar, Hameem
    Sigle, Monia
    Shune, Leyla
    McGuirk, Joseph
    Ganguly, Siddhartha
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S303 - S303
  • [23] Which strategy of immunoablative therapy with autologous stem cell transplantation (ASCT) is preferable in multiple sclerosis (MS) patients?
    Shevchenko, Yury L.
    Novik, Andrei A.
    Kuznetcov, Alexey N.
    Afanasiev, Boris A.
    Lisukov, Lgora.
    Rykavicin, Oleg A.
    Myasnikov, Alexandr A.
    Ionova, Tatyana I.
    Melnichenko, Vladimir J.
    Fedorenko, Denis A.
    Kishtovich, Anton V.
    Ivanov, Roman A.
    Gorodokin, Gary J.
    BLOOD, 2007, 110 (11) : 354B - 354B
  • [24] Lack of efficacy of high-dose chemotherapy (HDCT) and autologous stem cell transplantation (ASCT) for high risk locoregional recurrence of breast cancer.
    Vij, R
    Adkins, D
    Brown, R
    Goodnough, LT
    Khoury, H
    Westervelt, P
    Biondo, M
    Freytes, C
    Bachier, C
    DiPersio, J
    BLOOD, 1998, 92 (10) : 463A - 463A
  • [25] Autologous haematopoietic stem cell transplantation in multiple sclerosis patients: safety and efficacy in long term follow-up
    Radaelli, M.
    Moiola, L.
    Martinelli, V.
    Sangalli, F.
    Ferre, L.
    Barcella, V.
    Comola, M.
    Vezzulli, P.
    Greco, R.
    Peccatori, J.
    Ciceri, F.
    Comi, G.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 481 - 482
  • [26] High-dose chemotherapy with support for autologous hematopoietic stem cell transplantation in multiple sclerosis
    Fedulau, A.
    Barisau, A.
    Aghayev, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 496 - 496
  • [27] High dose chemotherapy (HDCT) with autologous stem cell transplantation (PBSCT) in patients with angioimmunoblastic T-cell lymphoma (AILD).
    Kingreen, D
    Reichle, A
    Fetscher, S
    Berdel, E
    Beguin, Y
    Brunet, S
    Caballero, D
    DeLaurenzi, A
    Hagberg, H
    Johnson, H
    Kimby, E
    López-Guillermo, A
    Stewart, D
    Copplestone, A
    Rösler, W
    Schetelig, J
    Siegert, W
    BLOOD, 1999, 94 (10) : 172A - 172A
  • [28] High-dose chemotherapy (HDCT) followed by autologous hematopoietic stem cell transplantation (HSCT) for patients with rhabdomyosarcomas (RMS)
    Peinemann, F.
    Hildebrandt, M.
    Kulig, M.
    Herrmann-Frank, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [29] Cost analysis of high dose chemotherapy and autologous stem cell transplantation (HDT/ASCT) in Greece
    Thanopoulou, I.
    Angelopoulou, M.
    Anargyrou, K.
    Tsirkinidis, P.
    Moschogiannis, M.
    Chatzileonida, E.
    Vassilakopoulos, T. P.
    Yakoumis, X.
    Konstadoulakis, K.
    Rombos, Y.
    Vaiopoulos, G.
    Polyzos, N.
    Pangalis, G. A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 434 - 435
  • [30] Successful treatment of HHV-6 induced secondary graft failure following high dose chemotherapy(HDCT) and autologous stem cell transplantation (ASCT).
    Vij, R
    Brown, R
    Khoury, H
    Adkins, D
    Goodnough, LT
    DiPersio, JF
    BLOOD, 1999, 94 (10) : 374B - 374B
12345